EquityFlow › Companies › Camena Bioscience

Camena Bioscience

Biotech · Cambridge, GB

Synthetic DNA / gene synthesis using its gSynth enzymatic platform.

Funding history

Date	Round	Amount
Jul 2023	Series A Cambridge synthetic-biology firm Camena Bioscience raised a USD10M Series A led by Mercia to scale its gSynth DNA-synthesis platform.	$9.2M

Mercia